Population
Patients requiring prevention or treatment of arterial and venous thromboembolism, including those…
Comparison
New oral anticoagulants, specifically direct… vs Warfarin
Design
Review
Authors
Loading...
May ease post-orthopedic VTE prophylaxis versus warfarin; leaves open confirmatory trials before routine adoption.
New oral anticoagulants targeting thrombin and factor Xa are poised to provide a safer and more convenient alternative to warfarin for the prevention and treatment of venous thromboembolism.
Zikria et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: